National and Kapodistrian University of Athens
Καρκίνος νεφρού, παχυσαρκία, ορμόνες λιπώδους ιστού και σύστημα IGF
Abstract
dc:descriptionRenal Cell Carcinoma (RCC) consists about 3% of malignant parenchymal tumors; the increasing incidence trend during last decades, which may be partially attributed to the development of imaging techniques. Obesity is an established risk factor for RCC, whereas adipose tissue hormones might be involved in complex pathways of homeostasis, inflammation and immunity, a factor which has attracted investigators to explore their potential role in carcinogenesis. In the context of a research protocol employing case control methodology and designed to study the association of obesity and its induced insulin resistance, as well as of levels of leptin and adiponectin with different cancer sites risk, this Thesis focused on RCC. An inverse association of adiponectin with RCC was found which was not modified after controlling forseveral potential confounding factors, except for WHR, which resulted in weakening of the observed association; this possibly implies that adiponectin may mediate the effects of central obesity on the development of RCC. Leptin levels were lower among patients compared to those among controls, even after controlling for potential confounders. Given the rather immunogenic nature of RCC, we proposed a possible pathogenetical mechanism that may connect leptin and the tumor development, at least partly via hormonal cross-talk with complex neuron-endocrine and immune circuits. Finally, when we investigated the association of insulin resistance with RCC, in contrast with other cancer sites, we found that insulin levels were inversely associated with RCC risk, even after controlling for glucose levels or other proxies of insulin resistance, like HOMA or other studied confounding factors. The published articles which are included in this thesis present for first time data in regards with RCC risk and adiponectin, leptin and insulin resistance. The possible methodological limitations due to study design are hightligted along with the efforts made to reduce systematic bias. In summary, our data pointed to the inverse relation of adiponectin with RCC risk, in line with reports regarding other tumor sites. Concerning the inverse also association of leptin and insulin resistance with RCC, we propose that it may be attributed to immune properties of leptin; complex interactions and cross talking might play a role, given the response of some RCC cases to immunotherapeutic agents. If the findings are confirmed by specifically designed studies they may influence the therapy and prognosis of patients suffering RCC or specific subtypes.
Degree
thesis:*- Grantor dc:publisher
- National and Kapodistrian University of Athens
- Year dc:date
- 2012
Author and committee
dc:creator, dc:contributor.*- Authors dc:creator
-
- Spyridopoulos, Themistoklis
- Σπυριδόπουλος, Θεμιστοκλής
Subjects
dc:subject × 20- Καρκίνος νεφρού
- Νεφροκυτταρικό καρκίνωμα
- Παχυσαρκία
- Αδιπονεκτίνη
- Λεπτίνη
- Ινσουλίνη
- Ινσουλινοαντοχή
- Αδιποκυτταροκίνες
- Kidney cancer
- Renal cell carcinoma
- Obesity
- Adiponectin
- Leptin
- Insulin
- Insulin resistance
- Adipocytokines
- Ιατρική και Επιστήμες Υγείας
- Κλινική Ιατρική
- Medical and Health Sciences
- Clinical Medicine
Rights
- Language dc:language
- gre
Identifiers
dc:identifier.*- Identifier
- 10.12681/eadd/29546